Caliper to raise $72 million in IPO (Initial Public Offering):
This article was originally published in Clinica
Executive Summary
Caliper Technologies is to raise $72 million in its Initial Public Offering, floating 4.5 million shares priced at $16. The Mountain View, California-based company is working on miniaturising in vitro diagnostics. Its LabChip device, in development, utilises minute amounts of sample and reagents and will provide diagnostics presently only provided by central laboratories. Low initial costs for the healthcare provider, plus the clinical advantages of moving the testing nearer the point-of-care, coupled with the increased sophistication of available microchip technology are said to be driving the "lab-on-a-chip" market.